Indication
In conjunction with diet and exercise for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis (consistent with fibrosis stages F2 to F3).
Medicine details
- Medicine name:
- resmetirom (Rezdiffra)
- SMC ID:
- SMC3016
- Pharmaceutical company
- Madrigal Pharmaceuticals
- BNF chapter
- Gastro-intestinal system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC